Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mobility Limitation | 8 | 2020 | 221 | 0.910 |
Why?
|
| Algorithms | 4 | 2018 | 517 | 0.710 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 2 | 0.620 |
Why?
|
| Disability Evaluation | 3 | 2019 | 238 | 0.620 |
Why?
|
| Transposition of Great Vessels | 1 | 2019 | 4 | 0.620 |
Why?
|
| Heart Failure, Systolic | 1 | 2019 | 15 | 0.620 |
Why?
|
| Aortic Diseases | 1 | 2019 | 62 | 0.590 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 115 | 0.590 |
Why?
|
| Geriatric Assessment | 5 | 2019 | 388 | 0.580 |
Why?
|
| Patient Care Team | 1 | 2019 | 123 | 0.580 |
Why?
|
| Psychometrics | 4 | 2019 | 137 | 0.570 |
Why?
|
| Exercise | 5 | 2020 | 688 | 0.460 |
Why?
|
| Cognition | 1 | 2018 | 553 | 0.430 |
Why?
|
| Video Recording | 2 | 2013 | 60 | 0.400 |
Why?
|
| Epistasis, Genetic | 3 | 2012 | 44 | 0.380 |
Why?
|
| Prostatic Neoplasms | 3 | 2012 | 476 | 0.370 |
Why?
|
| Models, Theoretical | 2 | 2014 | 138 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 837 | 0.360 |
Why?
|
| Aorta | 1 | 2012 | 127 | 0.360 |
Why?
|
| Aging | 4 | 2020 | 955 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2019 | 360 | 0.330 |
Why?
|
| Walking | 3 | 2020 | 212 | 0.330 |
Why?
|
| Health Status | 1 | 2013 | 403 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2019 | 1477 | 0.320 |
Why?
|
| Humans | 26 | 2020 | 32968 | 0.300 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 4065 | 0.300 |
Why?
|
| Aged | 15 | 2020 | 10637 | 0.290 |
Why?
|
| Male | 22 | 2020 | 19754 | 0.290 |
Why?
|
| Quality of Life | 2 | 2016 | 976 | 0.280 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 1152 | 0.270 |
Why?
|
| Computational Biology | 1 | 2008 | 96 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 950 | 0.260 |
Why?
|
| Female | 18 | 2020 | 20375 | 0.230 |
Why?
|
| Risk Factors | 8 | 2019 | 4001 | 0.230 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 183 | 0.210 |
Why?
|
| Computer Simulation | 2 | 2018 | 224 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 1068 | 0.190 |
Why?
|
| Age Factors | 5 | 2019 | 1202 | 0.180 |
Why?
|
| Time Factors | 4 | 2019 | 2195 | 0.170 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2020 | 4 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 424 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 80 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 770 | 0.160 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 11 | 0.160 |
Why?
|
| Psychology | 1 | 2019 | 24 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 85 | 0.150 |
Why?
|
| Cause of Death | 1 | 2019 | 240 | 0.140 |
Why?
|
| Physical Fitness | 1 | 2019 | 133 | 0.140 |
Why?
|
| Health Education | 2 | 2016 | 162 | 0.140 |
Why?
|
| European Continental Ancestry Group | 2 | 2013 | 1163 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2019 | 205 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2019 | 135 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3708 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 563 | 0.140 |
Why?
|
| Actigraphy | 1 | 2017 | 15 | 0.140 |
Why?
|
| Disease Progression | 1 | 2019 | 594 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 125 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 131 | 0.130 |
Why?
|
| Insulin | 2 | 2015 | 369 | 0.130 |
Why?
|
| Life Style | 2 | 2020 | 409 | 0.120 |
Why?
|
| Linear Models | 2 | 2019 | 445 | 0.120 |
Why?
|
| Middle Aged | 7 | 2019 | 12203 | 0.120 |
Why?
|
| Reference Values | 2 | 2015 | 238 | 0.120 |
Why?
|
| Research Design | 1 | 2018 | 334 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2016 | 108 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2017 | 282 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 894 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2014 | 104 | 0.110 |
Why?
|
| Single-Blind Method | 3 | 2020 | 196 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2019 | 1469 | 0.100 |
Why?
|
| Health Literacy | 1 | 2013 | 29 | 0.100 |
Why?
|
| Indians, North American | 1 | 2013 | 110 | 0.100 |
Why?
|
| Prognosis | 4 | 2020 | 1547 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 54 | 0.100 |
Why?
|
| Aortic Coarctation | 1 | 2012 | 4 | 0.100 |
Why?
|
| Iohexol | 1 | 2012 | 8 | 0.100 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2012 | 15 | 0.100 |
Why?
|
| Self Efficacy | 1 | 2013 | 81 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2012 | 880 | 0.090 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2012 | 18 | 0.090 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 38 | 0.090 |
Why?
|
| Quality Control | 1 | 2012 | 45 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 327 | 0.090 |
Why?
|
| Contrast Media | 1 | 2012 | 139 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3460 | 0.090 |
Why?
|
| Child | 2 | 2018 | 2478 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2010 | 30 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2012 | 694 | 0.080 |
Why?
|
| Infant | 1 | 2012 | 1083 | 0.070 |
Why?
|
| Adolescent | 2 | 2018 | 3643 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 1282 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 783 | 0.070 |
Why?
|
| Multifactorial Inheritance | 1 | 2008 | 23 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1179 | 0.060 |
Why?
|
| African Americans | 1 | 2013 | 1425 | 0.060 |
Why?
|
| Taiwan | 2 | 2020 | 10 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2008 | 134 | 0.060 |
Why?
|
| Hypoglycemia | 2 | 2015 | 42 | 0.060 |
Why?
|
| Sex Factors | 2 | 2019 | 684 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2020 | 146 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2019 | 148 | 0.040 |
Why?
|
| Acceleration | 1 | 2019 | 69 | 0.040 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 19 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 308 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2020 | 410 | 0.030 |
Why?
|
| Tobacco Use Disorder | 1 | 2018 | 90 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2020 | 421 | 0.030 |
Why?
|
| Alcoholism | 1 | 2018 | 102 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 67 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 40 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 780 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 265 | 0.030 |
Why?
|
| Resistance Training | 1 | 2016 | 79 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 9586 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 156 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 290 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2016 | 219 | 0.030 |
Why?
|
| Culture | 1 | 2014 | 39 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1246 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2015 | 363 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 622 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2738 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 765 | 0.030 |
Why?
|
| Medicine | 1 | 2013 | 40 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2014 | 163 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2015 | 495 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 909 | 0.020 |
Why?
|
| Minority Groups | 1 | 2013 | 87 | 0.020 |
Why?
|
| Arthritis | 1 | 2013 | 42 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 119 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 867 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2013 | 172 | 0.020 |
Why?
|
| Weight Loss | 1 | 2014 | 462 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2012 | 246 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1852 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 551 | 0.020 |
Why?
|
| North Carolina | 1 | 2013 | 1550 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4132 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2010 | 205 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2008 | 126 | 0.020 |
Why?
|
| Genotype | 1 | 2008 | 731 | 0.020 |
Why?
|
| Hypertension | 1 | 2013 | 983 | 0.020 |
Why?
|